Floatz logo

Cilastatin

Bacterial Pneumonia

Hartford HospitalSmall moleculePhase 4 / ApprovedActive
B
59/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
44/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Bacterial Pneumonia cohort.

Asset / SponsorPhaseRating
Cefiderocol
Hartford Hospital
Phase 4BB
Imipenem
Hartford Hospital
Phase 4BB
Relebactam
Hartford Hospital
Phase 4CCC

Same molecule, other indications

Cilastatin is also rated in:

cystic fibrosisActive
B
Indicative · Phase 4
56 / 100
View asset →
hematopoietic and lymphoid cell neoplasmActive
CCC
Indicative · Phase 2
54 / 100
View asset →
cancerActive
CCC
Indicative · Phase 2
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →